Zobrazeno 1 - 10
of 200
pro vyhledávání: '"Jørn Herrstedt"'
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 3, p 897 (2024)
Background: This phase II study evaluated the efficacy and safety of the histone deacetylase (HDAC) inhibitor, vorinostat, administered in combination with paclitaxel and carboplatin in patients with platinum sensitive recurrent ovarian cancer. Metho
Externí odkaz:
https://doaj.org/article/b16797c7e0f8462f9dff526026ace7c1
Autor:
Helena S. H. Dominiak, Simone D. Hasselsteen, Sebastian W. Nielsen, Jens Rikardt Andersen, Jørn Herrstedt
Publikováno v:
Nutrients, Vol 15, Iss 13, p 3014 (2023)
Introduction: Taste alteration is a common adverse effect of chemotherapy. This study aimed to investigate the effect of cannabidiol (CBD) on Lean Body Mass (LBM), and taste alterations during oxaliplatin- or paclitaxel-based chemotherapy. Methods: L
Externí odkaz:
https://doaj.org/article/8f0f105e09f44b1bad856f595d9639ca
Autor:
Birgitte Bjørnhart, Karin Holmskov Hansen, Trine Lembrecht Jørgensen, Jørn Herrstedt, Tine Schytte
Publikováno v:
Thrombosis Update, Vol 4, Iss , Pp 100056- (2021)
Background: Besides the cancer itself, venous thromboembolism (VTE) is the leading cause of death in cancer patients receiving outpatient chemotherapy (CT). Data on VTE development and impact on treatment course and outcome in real-life NSCLC patient
Externí odkaz:
https://doaj.org/article/dc14b99456fa443a8f009f5dea9da707
Autor:
Birgitte Bjørnhart, Karin Holmskov Hansen, Jon Thor Asmussen, Trine Lembrecht Jørgensen, Jørn Herrstedt, Tine Schytte
Publikováno v:
Cancers, Vol 14, Iss 7, p 1682 (2022)
Sparse data exist on immune checkpoint inhibition (ICI) in NSCLC patients with brain metastasis (BM), especially for those with no local therapy (LT) (whole brain radiation therapy (WBRT), stereotactic RT (SRT) or neurosurgery) preceding ICI. Our aim
Externí odkaz:
https://doaj.org/article/f90d69f84cc7422eb529f32a2f9517f6
Autor:
Sebastian W. Nielsen, Sanne Lindberg, Christina Halgaard Bruvik Ruhlmann, Lise Eckhoff, Jørn Herrstedt
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 7, p 1862 (2022)
(1) The study evaluated correlations between multi-frequency vibrometry (MF-V) and the measure of chemotherapy-induced peripheral neuropathy developed by the European Organization for the Research and Treatment of Cancer (CIPN18). (2) Patients with c
Externí odkaz:
https://doaj.org/article/0cd53c1f765546518efc69c809ddc633
Publikováno v:
Drugs - Real World Outcomes, Vol 5, Iss 4, Pp 225-235 (2018)
Abstract Background The number of older patients with cancer is increasing in general, and ovarian and endometrial cancer are to a large extent cancers of the elderly. Older patients with cancer have a high prevalence of comorbidity. Comorbidity and
Externí odkaz:
https://doaj.org/article/8507c990fe344e878e8e19cbb7ce46e1
Autor:
Christian B. van Randwijk, Tobias Opsahl, Elisabeth Assing Hvidt, Tobias Kvist Stripp, Lars Bjerrum, Jørn Herrstedt, Jens Søndergaard, Niels Christian Hvidt
Publikováno v:
Religions, Vol 12, Iss 2, p 116 (2021)
Many physicians remain reticent to initiate or partake in discussions about their patients’ religious and spiritual needs during the clinical encounter. Reasons for this may be insufficient time, capacity, education or training but may also be a pr
Externí odkaz:
https://doaj.org/article/7cf54f602aa24b86a2cea39353caa5d2
Autor:
Enriqueta Felip, Josep Tabernero, Maria De Santis, Emile Voest, Mark Robson, Fatima Cardoso, Elisabeth G E de Vries, Fedro Alessandro Peccatori, Svetlana Jezdic, Giannis Mountzios, Smita Bhatia, Alexandru Eniu, Luzia Travado, Ulrich Keilholz, Jonas Bergh, Jan Buckner, Friedrich Stiefel, Ahmad Awada, Cristiana Sessa, Olivier Michielin, Marc Ernstoff, Ben Markman, Lisa Licitra, Rossana Berardi, Jill Gilbert, Lidia Schapira, Eva Schernhammer, Jeffrey S Weber, Heinz-Josef Lenz, Piotr Rutkowski, Jennifer Duff, Axel Grothey, Yuichiro Ohe, Saskia Litiere, Hans Wildiers, Christian Dittrich, Michael Kosty, Doug Pyle, Nagi El-Saghir, Jean-Pierre Lotz, Pia Österlund, Nicholas Pavlidis, Gunta Purkalne, Susana Banerjee, Jan Bogaerts, Paolo Casali, Edward Chu, Julia Lee Close, Bertrand Coiffier, Roisin Connolly, Sarah Coupland, Luigi De Petris, Don S Dizon, Linda R Duska, Martin F Fey, Nicolas Girard, Andor W J M Glaudemans, Priya K Gopalan, Stephen M Hahn, Diana Hanna, Christian Herold, Jørn Herrstedt, Krisztian Homicsko, Dennie V Jones, Lorenz Jost, Saad Khan, Alexander Kiss, Claus-Henning Köhne, Rainer Kunstfeld, Stuart Lichtman, Thomas Lion, Lifang Liu, Patrick J Loehrer, Merry Jennifer Markham, Marius Mayerhoefer, Johannes G Meran, Elizabeth Charlotte Moser, Timothy Moynihan, Torsten Nielsen, Kjell Öberg, Antonio Palumbo, Michael Pfeilstöcker, Chandrajit Raut, Scot C Remick, Roberto Salgado, Martin Schlumberger, Hans-Joachim Schmoll, Lowell Schnipper, Charles L Shapiro, Julie Steele, Cora N Sternberg, Florian Strasser, Roger Stupp, Richard Sullivan, Marcel Verheij, Everett Vokes, Jamie Von Roenn, Yosef Yarden
Publikováno v:
ESMO Open, Vol 1, Iss 5 (2016)
The European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO) are publishing a new edition of the ESMO/ASCO Global Curriculum (GC) thanks to contribution of 64 ESMO-appointed and 32 ASCO-appointed authors. Firs
Externí odkaz:
https://doaj.org/article/03442ec458e245ef83ebe8453a3f265c
Autor:
Christina Ruhlmann, Jørn Herrstedt
Publikováno v:
Therapeutics and Clinical Risk Management, Vol 2009, Iss default, Pp 375-384 (2009)
Christina Ruhlmann, Jørn HerrstedtOdense University Hospital, Department of Oncology, Odense, DenmarkAbstract: Chemotherapy-induced nausea and vomiting (CINV) are among the most feared and distressing symptoms experienced by patients with cancer. Th
Externí odkaz:
https://doaj.org/article/eae8ba13fdaf4a14bf811b8717eb9cc3
Autor:
Rudolph Navari, Gary Binder, Alex Molasiotis, Jørn Herrstedt, Eric J Roeland, Kathryn J Ruddy, Thomas W LeBlanc, Dwight D Kloth, Kelsey A Klute, Eros Papademetriou, Luke Schmerold, Lee Schwartzberg
Publikováno v:
The Oncologist. 28:208-213
Background The relationship between CINV duration and recurrence in subsequent cycles is largely unstudied. Our objective was to determine if patients experiencing CINV in their first cycle of chemotherapy (C1) would face increased risk of CINV in la